Annual EBITDA
-$22.15 M
-$3.45 M-18.43%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual EBITDA is -$22.15 million, with the most recent change of -$3.45 million (-18.43%) on June 30, 2024.
- During the last 3 years, BNTC annual EBITDA has fallen by -$8.70 million (-64.64%).
- BNTC annual EBITDA is now -907.99% below its all-time high of $2.74 million, reached on June 30, 2019.
Performance
BNTC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.70 M
-$316.00 K-5.87%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly EBITDA is -$5.70 million, with the most recent change of -$316.00 thousand (-5.87%) on September 30, 2024.
- Over the past year, BNTC quarterly EBITDA has increased by +$1.01 million (+15.08%).
- BNTC quarterly EBITDA is now -814.46% below its all-time high of $797.80 thousand, reached on September 30, 2016.
Performance
BNTC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$21.98 M
+$92.00 K+0.42%
September 30, 2024
Summary
- As of February 7, 2025, BNTC TTM EBITDA is -$21.98 million, with the most recent change of +$92.00 thousand (+0.42%) on September 30, 2024.
- Over the past year, BNTC TTM EBITDA has dropped by -$1.06 million (-5.06%).
- BNTC TTM EBITDA is now -2695.85% below its all-time high of -$786.20 thousand, reached on March 31, 2015.
Performance
BNTC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BNTC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | +15.1% | -5.1% |
| 3 y3 years | -64.6% | +15.1% | -5.1% |
| 5 y5 years | -908.0% | +15.1% | -5.1% |
BNTC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -64.6% | at low | -80.9% | +15.1% | -31.7% | +0.4% |
| 5 y | 5-year | -908.0% | at low | -182.7% | +15.1% | -591.2% | +0.4% |
| alltime | all time | -908.0% | at low | -814.5% | +15.1% | -2695.8% | +0.4% |
Benitec Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.70 M(+5.9%) | -$21.98 M(-0.4%) |
| Jun 2024 | -$22.15 M(+18.4%) | -$5.38 M(+28.6%) | -$22.07 M(+6.1%) |
| Mar 2024 | - | -$4.18 M(-37.6%) | -$20.81 M(-0.5%) |
| Dec 2023 | - | -$6.71 M(+15.9%) | -$20.92 M(+7.2%) |
| Sep 2023 | - | -$5.79 M(+40.5%) | -$19.51 M(+4.3%) |
| Jun 2023 | -$18.70 M(+5.2%) | -$4.12 M(-4.1%) | -$18.70 M(-4.5%) |
| Mar 2023 | - | -$4.30 M(-18.9%) | -$19.57 M(+6.2%) |
| Dec 2022 | - | -$5.30 M(+6.4%) | -$18.43 M(+3.4%) |
| Sep 2022 | - | -$4.98 M(-0.2%) | -$17.82 M(+0.2%) |
| Jun 2022 | -$17.78 M(+32.2%) | -$4.99 M(+58.5%) | -$17.78 M(+6.6%) |
| Mar 2022 | - | -$3.15 M(-32.9%) | -$16.69 M(-3.7%) |
| Dec 2021 | - | -$4.70 M(-5.0%) | -$17.33 M(+9.9%) |
| Sep 2021 | - | -$4.94 M(+26.7%) | -$15.77 M(+17.5%) |
| Jun 2021 | -$13.45 M(+70.1%) | -$3.90 M(+2.8%) | -$13.43 M(+8.9%) |
| Mar 2021 | - | -$3.79 M(+21.0%) | -$12.33 M(+16.8%) |
| Dec 2020 | - | -$3.13 M(+20.7%) | -$10.55 M(+10.7%) |
| Sep 2020 | - | -$2.60 M(-7.2%) | -$9.53 M(+19.1%) |
| Jun 2020 | -$7.91 M | -$2.80 M(+38.9%) | -$8.00 M(+53.9%) |
| Mar 2020 | - | -$2.02 M(-4.5%) | -$5.20 M(+63.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$2.11 M(+97.5%) | -$3.18 M(+197.5%) |
| Sep 2019 | - | -$1.07 M(-52.4%) | -$1.07 M(-87.6%) |
| Jun 2019 | $2.74 M(-131.9%) | - | - |
| Jun 2018 | -$8.59 M(+104.9%) | -$2.24 M(+10.1%) | -$8.59 M(+2.3%) |
| Mar 2018 | - | -$2.04 M(-5.0%) | -$8.40 M(+31.7%) |
| Dec 2017 | - | -$2.14 M(-0.7%) | -$6.38 M(-10.8%) |
| Sep 2017 | - | -$2.16 M(+5.2%) | -$7.15 M(+70.6%) |
| Jun 2017 | -$4.19 M(-73.4%) | -$2.05 M(>+9900.0%) | -$4.19 M(-17.4%) |
| Mar 2017 | - | -$18.10 K(-99.4%) | -$5.07 M(-28.2%) |
| Dec 2016 | - | -$2.92 M(-465.6%) | -$7.07 M(-21.1%) |
| Sep 2016 | - | $797.80 K(-127.2%) | -$8.96 M(-43.1%) |
| Jun 2016 | -$15.74 M(+98.5%) | -$2.94 M(+46.0%) | -$15.74 M(+1.1%) |
| Mar 2016 | - | -$2.01 M(-58.2%) | -$15.58 M(+8.5%) |
| Dec 2015 | - | -$4.81 M(-19.6%) | -$14.35 M(+50.4%) |
| Sep 2015 | - | -$5.98 M(+116.0%) | -$9.54 M(+168.2%) |
| Jun 2015 | -$7.93 M(-23.5%) | -$2.77 M(+252.4%) | -$3.56 M(+352.4%) |
| Mar 2015 | - | -$786.20 K | -$786.20 K |
| Jun 2014 | -$10.37 M(+53.9%) | - | - |
| Jun 2013 | -$6.74 M | - | - |
FAQ
- What is Benitec Biopharma annual EBITDA?
- What is the all time high annual EBITDA for Benitec Biopharma?
- What is Benitec Biopharma annual EBITDA year-on-year change?
- What is Benitec Biopharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Benitec Biopharma?
- What is Benitec Biopharma quarterly EBITDA year-on-year change?
- What is Benitec Biopharma TTM EBITDA?
- What is the all time high TTM EBITDA for Benitec Biopharma?
- What is Benitec Biopharma TTM EBITDA year-on-year change?
What is Benitec Biopharma annual EBITDA?
The current annual EBITDA of BNTC is -$22.15 M
What is the all time high annual EBITDA for Benitec Biopharma?
Benitec Biopharma all-time high annual EBITDA is $2.74 M
What is Benitec Biopharma annual EBITDA year-on-year change?
Over the past year, BNTC annual EBITDA has changed by -$3.45 M (-18.43%)
What is Benitec Biopharma quarterly EBITDA?
The current quarterly EBITDA of BNTC is -$5.70 M
What is the all time high quarterly EBITDA for Benitec Biopharma?
Benitec Biopharma all-time high quarterly EBITDA is $797.80 K
What is Benitec Biopharma quarterly EBITDA year-on-year change?
Over the past year, BNTC quarterly EBITDA has changed by +$1.01 M (+15.08%)
What is Benitec Biopharma TTM EBITDA?
The current TTM EBITDA of BNTC is -$21.98 M
What is the all time high TTM EBITDA for Benitec Biopharma?
Benitec Biopharma all-time high TTM EBITDA is -$786.20 K
What is Benitec Biopharma TTM EBITDA year-on-year change?
Over the past year, BNTC TTM EBITDA has changed by -$1.06 M (-5.06%)